Molbio Diagnostics down 2% even after Q2 profit reported
Molbio Diagnostics shares fell 2% after reporting consolidated profit of ₹58.7 crore in Q2 versus a ₹23.7 crore loss in the year-ago period.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Molbio Diagnostics shares fell 2% after reporting consolidated profit of ₹58.7 crore in Q2 versus a ₹23.7 crore loss in the year-ago period.